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Available online 21 June 2014With the advances in imaging technology, resolution and
identificationof images have improved. Breast ultrasoundas a
screening tool for breast cancer is a very popular topic. A few
years ago, the Health Promotion Administration of the Minis-
try of Health and Welfare attempted to integrate related
specialties countrywide, including obstetrics and gynecology,
family medicine, radiology, and breast surgery, to formulate
common criteria for developing an ultrasound-based breast
cancer screening guideline suitable for women in Taiwan.
Since 2003, the Taiwan Association of Obstetrics and
Gynecology has been offering breast ultrasound examination
technique training to medical specialists. Headed by Pro-
fessor Fon-Jou Hsieh, the instructors’ training classes were
established, and the first training was complete for the
charter group of approximately 20 obstetricianegynecolo-
gists in breast ultrasound examination. With the strong
support of two breast surgeons, Professors King-Jen Chang
and Ming-Feng Hou, and locations chosen by the Taiwan So-
ciety of Ultrasound in Medicine for practical ultrasound field
training, we were able to become familiar with performing
breast ultrasound examinations within a very short time. The
author was the class leader of the training class, and was
responsible for the smooth implementation of the program
and arrangement of subsequent ultrasound field trainings.
In 2008e2009, the Taiwan Association of Obstetrics and
Gynecologycompleted the two-level “basic”and“advanced”Conflicts of interest: The author declares no conflicts of
interest.
* Dr. Ming-Kwang Shyu, Department of Obstetrics and Gynecol-
ogy, National Taiwan University Hospital, Number 7, Chung-Shan
South Road, Taipei, Taiwan.
E-mail address: shyumk@ntu.edu.tw.
http://dx.doi.org/10.1016/j.jmu.2014.05.005
0929-6441/ª 2014, Elsevier Taiwan LLC and the Chinese Taipei Societytraining classes for breast ultrasound examinations in the
northern, central, and southern regions of Taiwan, under the
leadership of three presidents (Drs Maw-Sheng Lee, Yu-Shih
Yang, and Horng-Der Tsai), with assistance from the special-
ists of the Breast Cancer Society of Taiwan and the Taiwan
Society of Ultrasound in Medicine. At the time, a total of
approximately 500 members completed the compulsory
course in the breast ultrasound examination technique and
passed the final test, thus enabling obstetricianegynecolo-
gists to participate in breast ultrasound examinations for
breast cancer screening within a very short time.
However, the promotion of breast ultrasound as a first-
line screening tool for comprehensive breast cancer
screening in Taiwan has encountered some difficulties. The
reasons are complicated and cannot be explained in brief.
Nevertheless, some of the reasons are described herein.
(1) Massive funding requirement: Using breast ultrasound
as the only tool for breast cancer screening resulted in
a detection rate of 7.6 breast cancer cases per 1000
persons in a high-risk female population with 50%
sensitivity, as reported by Berg et al (2008) [1] in
JAMA. In the report, the ultrasound and mammog-
raphy detection rates and sensitivities were similar. In
recent years, newly diagnosed breast cancer cases
exceeded 7000 persons per year. If the breast ultra-
sound detection rate is 3e4/1000 in women at average
risks, approximately 2 million women should be
screened every year. If the cost of screening is NT$700
per person, the Health Promotion Administration must
allocate NT$1.4 billion per year. Even if there is suf-
ficient funding, the available funds will be exhausted
soon, which the Legislative Yuan will not accept.of Ultrasound in Medicine. Open access under CC BY-NC-ND license.
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ety of Taiwan has approximately 600 members,
including clinical surgeons, only a small proportion
participates in practical breast ultrasound examina-
tions. Among family physicians, radiologists (most of
whom are members of the Breast Cancer Society of
Taiwan), and gynecologists, only 200e300 physicians
are able to perform routine breast ultrasound exam-
inations. Thus, every physician will screen 10,000
cases per year. However, performing screening ex-
aminations, in addition to their regular jobs, places
an additional load on the medical personnel, and they
may not be able to cope with it. Moreover, hospitals
do not have extra space for such a large program.
(3) Pre-existing limitations of breast ultrasound: Based on
the present imaging ability, nonpalpable breast tu-
mors and early ductal carcinoma in situ (DCIS) are the
most troublesome shortcomings of breast ultrasound
for breast cancer screening. Only mammography
screening meets this requirement. Yang (2004) [2] re-
ported in AJR that ultrasound detected 90% (54/60) of
DCIS cases, which is impressive. According to Dr Chen,
the Immediate Past President of the Taiwan Society of
Ultrasound in Medicine, general practitioners will have
difficulties detecting 100% of DCIS cases using ultra-
sound. Shin (2008) [3] reported in AJR that ultrasound
detected 89% (95/106) of DCIS cases in a high-risk
population, 74% of which were mass lesions. For the
ultrasound characteristics and examination principles
of these two types of lesions, we should consult the
Chairman, Dr Chen. If the Taiwan Society of Ultrasound
in Medicine has arranged any lectures, please attend
as many as possible. In 2004, the Health Promotion
Administration commissioned a 5-year plan. Professor
Chiun-Sheng Huang of the National Taiwan University
Hospital was the principle investigator. The 5-year
plan was a randomized trial combining samples from
several medical centers and regional hospitals in
Taiwan to screenwomen aged between 40 years and 49
years, and showed that mammography was the first-
line screening tool, with a screening sensitivity of
90.6%; DCIS accounted for 32.5% of the cases. When
breast ultrasound was used as the first-line screening
tool, the screening sensitivity was 60.1%, of which the
majority wasmass lesions, and DCIS accounted for only
16% of the cases. Based on the existing data, the use of
ultrasound as the first-line breast cancer screening
tool is not effective because DCIS is often missed.
When false-negatives occur too often during
“screening”, we need to consider the possibility of
being liable and have to proceed with great caution.
Therefore, the Health Promotion Administration
changed the screening policy and recommended that the
general female population aged >45 years should undergo
routine regular mammography screening. Other high-risk
females with a family history of breast cancer should
receive routine mammography screening starting at 40
years of age. The population of women being screened is
much smaller, and the feasibility and rationale are
considered reasonable. What is the future of breast
ultrasound?We need to investigate this issue as a niche in cancer
screening.
Effective screening brings at least three benefits: the
tumor is smaller at discovery; the chance of lymphatic
metastasis is lower; and the tumor stage is earlier. Thus,
the greatest benefit of screening is to detect a rapidly
growing tumor earlier. A tumor with a larger diameter is
more likely to be a late-stage tumor. In a textbook by Tabar
(2005) [4], after logistic regression analysis, the odds ratio
of a grade 3 tumor is 1.83 for a breast tumor 10e14 mm in
diameter; however, the odds ratio is 3.76 if the tumor is
15e19 mm in diameter. When the diameter of the tumor
exceeds 20 mm, the odds ratio of a grade 3 tumor is >5.83.
Therefore, the primary goal of breast ultrasound is to
detect tumors <20 mm in diameter. Breast ultrasound does
not necessarily detect occult DCIS.
In addition, the analysis by Tabar also showed that the
proportion of grade 3 tumors <1 cm in diameter in the
40e49 years, 50e59 years, and 60e69 years age groups
were 19.1%, 14.9%, and 11.9%, respectively. Thus, younger
patients have a higher probability of having grade 3 breast
cancer, suggesting that breast cancer screening is most
beneficial for young women, thereby enhancing the
detection of tumors. Of note, dense tissues in young breasts
may interfere with mammography and affect the detection
rate (Kolb et al, 2002) [5]. Therefore, the advantage of
breast ultrasound is achieving the same sensitivity in breast
tissues of different densities.
Most obstetricianegynecologists perform ultrasound ex-
aminations. Indeed, obstetricianegynecologists canperform
complicated examinations to screen for fetal abnormalities;
the diagnosis of breast tumors should not be obstacles. The
real pitfall is whether or not we fully understand the limi-
tations of using breast ultrasound for breast cancer screening
and the information we can provide. Thus, the problem is
how you interpret it.
In summary, attempting to use breast ultrasound to
perform breast cancer screening is extremely dangerous;
however, if the new generation of ultrasound is used to
make the differential diagnosis of “visible” breast tumors,
it will be powerful and appropriate. Professor Hsieh, the
Immediate Past President of the Taiwan Association of
Obstetrics and Gynecology, has emphasized the importance
of breast ultrasound examination training: “We will
continue to cooperate with the Taiwan Society of Ultra-
sound in Medicine and the Breast Cancer Society of Taiwan
to arrange continuing education for our members.”
The take-home messages we bring to you are as follows:
(1) Currently, ultrasound is not an appropriate tool for
first-line breast cancer screening.
(2) The examiner should receive training to be familiar
with the steps of the examination.
(3) At the same time, information provided by mammog-
raphy should be fully integrated with the findings of
ultrasound.
(4) If feasible, fine needle aspiration should be completed
as well. It can provide the best service and reference
for diagnosis and treatment.
Let us work hard together.
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